4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000899243-23-009178
Chief Medical Officer sold 54,627 shares at an average $31.87 ($1,741,200)
- Chief Medical Officer acquired 9,167 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Yeramian Patrick D Chief Medical Officer | 2023-03-16 | Sale | −52,211 | $31.85 | $1,662,842 | 152,088 | D |
| Yeramian Patrick D Chief Medical Officer | 2023-03-16 | Sale | −2,416 | $32.43 | $78,358 | 149,672 | D |
| Yeramian Patrick D Chief Medical Officer | 2023-03-16 | Grant or award | +9,167 | 158,839 | D | ||
| Derivatives | |||||||
| Yeramian Patrick D Chief Medical Officer | 2023-03-16 | Grant or award · Stock Option (right to buy) | +41,250 | 41,250 | D | ||
| Open-market sales · 54,627 sh · avg $31.87 · $1,741,200 | |||||||
Loading xslF345X04/doc4.xml…